10-K Filing

Silo Pharma, Inc. CIK: 1514183 FY 2013

Filing Information

Form Type	10-K
Accession Number	`0001213900-14-002019`
Period End Date	20131231
Filing Date	20140331
Fiscal Year	2013
Fiscal Period	FY
XBRL Instance	gldsw-20131231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 49 Income Statement 38 Cash Flow Statement 61 Stockholders Equity 20

Balance Sheet 49 line items

Line Item	Tag	Value	Unit	Period
Non-affiliated investments cost	`InvestmentOwnedAtCost`	$131.02K	USD	Point-in-time
Non-affiliated investments cost	`InvestmentOwnedAtCost`	-	USD	Point-in-time
Non-controlled/Non-affiliated investments (cost $131,023 and $0)	`InvestmentsInNonAffiliates`	-	USD	Point-in-time
Non-controlled/Non-affiliated investments (cost $131,023 and $0)	`InvestmentsInNonAffiliates`	$196.16K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$47.48K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$1.75K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$2.01M	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$279.00	USD	Point-in-time
Interest receivable	`InterestReceivable`	$600.00	USD	Point-in-time
Interest receivable	`InterestReceivable`	-	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total Assets	`Assets`	$279.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total Assets	`Assets`	$2.21M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	40.61M	shares	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$20.69K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	30.63M	shares	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$2.05K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	40.61M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	30.63M	shares	Point-in-time
Notes payable	`NotesPayable`	$15.00K	USD	Point-in-time
Notes payable	`NotesPayable`	$20.00K	USD	Point-in-time
Interest payable	`InterestPayableCurrentAndNoncurrent`	$782.00	USD	Point-in-time
Interest payable	`InterestPayableCurrentAndNoncurrent`	$1.67K	USD	Point-in-time
Total Liabilities	`Liabilities`	$41.47K	USD	Point-in-time
Total Liabilities	`Liabilities`	$18.72K	USD	Point-in-time
Redeemable Series A, Convertible Preferred stock, $0.0001 par value, 5,000,000 shares authorized; 4,000 and none issued and outstanding ($100 per share redemption value)	`PreferredStockValue`	$400.00K	USD	Point-in-time
Common stock, $0.0001 par value, 100,000,000 shares authorized; 40,606,200 and 30,631,200 shares issued and outstanding	`CommonStockValue`	$4.06K	USD	Point-in-time
Common stock, $0.0001 par value, 100,000,000 shares authorized; 40,606,200 and 30,631,200 shares issued and outstanding	`CommonStockValue`	$3.06K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$2.92M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.12M	USD	Point-in-time
Accumulated net investment loss	`AccumulatedNetInvestmentGainLoss`	-	USD	Point-in-time
Accumulated net investment loss	`AccumulatedNetInvestmentGainLoss`	$-71.99K	USD	Point-in-time
Accumulated undistributed net realized gains on investments	`AccumulatedUndistributedNetRealizedGainOrLoss`	$39.75K	USD	Point-in-time
Accumulated undistributed net realized gains on investments	`AccumulatedUndistributedNetRealizedGainOrLoss`	-	USD	Point-in-time
Unrealized appreciation on investments	`InvestmentOwnedUnrecognizedUnrealizedAppreciation`	-	USD	Point-in-time
Unrealized appreciation on investments	`InvestmentOwnedUnrecognizedUnrealizedAppreciation`	$-65.14K	USD	Point-in-time
Accumulated deficit during development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$1.17M	USD	Point-in-time
Accumulated deficit during development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$1.17M	USD	Point-in-time
Total Net Assets (Deficit)	`StockholdersEquity`	$-41.19K	USD	Point-in-time
Total Net Assets (Deficit)	`StockholdersEquity`	$-1.75K	USD	Point-in-time
Total Net Assets (Deficit)	`StockholdersEquity`	$47.48K	USD	Point-in-time
Total Net Assets (Deficit)	`StockholdersEquity`	$1.79M	USD	Point-in-time
Total Liabilities and Net Assets (Deficit)	`LiabilitiesAndStockholdersEquity`	$2.21M	USD	Point-in-time
Total Liabilities and Net Assets (Deficit)	`LiabilitiesAndStockholdersEquity`	$279.00	USD	Point-in-time
Net Asset Value per common share	`NetAssetValuePerShare`	$0.04	USD	Point-in-time
Net Asset Value per common share	`NetAssetValuePerShare`	-	USD	Point-in-time

Income Statement 38 line items

Line Item	Tag	Value	Unit	Period
Non-controlled/Non-affiliated investments	`InvestmentIncomeInterest`	-	USD	Annual
Non-controlled/Non-affiliated investments	`InvestmentIncomeInterest`	$625.00	USD	Annual
Non-controlled/Non-affiliated investments	`InvestmentIncomeInterest`	-	USD	Annual
Professional fees	`ProfessionalFees`	$52.02K	USD	Annual
Filing fees	`OtherGeneralExpense`	$10.30K	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$39.45K	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$49.80K	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$10.30K	USD	Annual
Total expenses	`CostsAndExpenses`	$72.61K	USD	Annual
Total expenses	`CostsAndExpenses`	$39.45K	USD	Annual
Total expenses	`CostsAndExpenses`	$49.80K	USD	Annual
Net investment loss	`NetInvestmentGainLoss`	-	USD	Annual
Net investment loss	`NetInvestmentGainLoss`	-	USD	Annual
Net investment loss	`NetInvestmentGainLoss`	$-71.99K	USD	Annual
Non-controlled/Non-affiliated investments	`RealizedInvestmentGainsLosses`	$39.75K	USD	1 Quarter
Non-controlled/Non-affiliated investments	`RealizedInvestmentGainsLosses`	-	USD	Annual
Non-controlled/Non-affiliated investments	`RealizedInvestmentGainsLosses`	-	USD	Annual
Non-controlled/Non-affiliated investments	`RealizedInvestmentGainsLosses`	$39.75K	USD	Annual
Non-controlled/Non-affiliated investments	`UnrealizedInvestmentGainsLosses`	-	USD	Annual
Non-controlled/Non-affiliated investments	`UnrealizedInvestmentGainsLosses`	$65.14K	USD	1 Quarter
Non-controlled/Non-affiliated investments	`UnrealizedInvestmentGainsLosses`	$65.14K	USD	Annual
Non-controlled/Non-affiliated investments	`UnrealizedInvestmentGainsLosses`	-	USD	Annual
Net realized and unrealized gain on investments	`GainLossOnInvestments`	$104.90K	USD	Annual
Net realized and unrealized gain on investments	`GainLossOnInvestments`	-	USD	Annual
Net realized and unrealized gain on investments	`GainLossOnInvestments`	-	USD	Annual
NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS	`IncreaseDecreaseInOperatingAssets`	$32.91K	USD	Annual
NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS	`IncreaseDecreaseInOperatingAssets`	-	USD	Annual
NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS	`IncreaseDecreaseInOperatingAssets`	-	USD	Annual
NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS	`IncreaseDecreaseInOperatingAssets`	$84.01K	USD	1 Quarter
Net loss	`NetIncomeLoss`	-	USD	Annual
Net loss	`NetIncomeLoss`	$-39.45K	USD	Annual
Net loss	`NetIncomeLoss`	$-49.80K	USD	Annual
Net loss per common share - basic and diluted	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	-	USD	Annual
Net loss per common share - basic and diluted	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	-	USD	Annual
Net loss per common share - basic and diluted	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	-	USD	Annual
Weighted average number of common shares outstanding during the period - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	-	shares	Annual
Weighted average number of common shares outstanding during the period - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	30.63M	shares	Annual
Weighted average number of common shares outstanding during the period - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	30.63M	shares	Annual

Cash Flow Statement 61 line items

Line Item	Tag	Value	Unit	Period
Net increase (decrease) in net assets resulting from operations	`IncreaseDecreaseInOperatingAssets`	$32.91K	USD	Annual
Net increase (decrease) in net assets resulting from operations	`IncreaseDecreaseInOperatingAssets`	-	USD	Annual
Net increase (decrease) in net assets resulting from operations	`IncreaseDecreaseInOperatingAssets`	-	USD	Annual
Net increase (decrease) in net assets resulting from operations	`IncreaseDecreaseInOperatingAssets`	$84.01K	USD	1 Quarter
Net loss	`NetIncomeLoss`	-	USD	Annual
Net loss	`NetIncomeLoss`	$-39.45K	USD	Annual
Net loss	`NetIncomeLoss`	$-49.80K	USD	Annual
Purchases of investments	`PaymentsToAcquireInvestments`	-	USD	Annual
Purchases of investments	`PaymentsToAcquireInvestments`	$180.00K	USD	Annual
Purchases of investments	`PaymentsToAcquireInvestments`	-	USD	Annual
Net realized gain on investments	`RealizedInvestmentGainsLosses`	$39.75K	USD	1 Quarter
Net realized gain on investments	`RealizedInvestmentGainsLosses`	-	USD	Annual
Net realized gain on investments	`RealizedInvestmentGainsLosses`	-	USD	Annual
Net realized gain on investments	`RealizedInvestmentGainsLosses`	$39.75K	USD	Annual
Net unrealized gains on investments	`UnrealizedGainLossOnInvestments`	$65.14K	USD	Annual
Net unrealized gains on investments	`UnrealizedGainLossOnInvestments`	-	USD	Annual
Net unrealized gains on investments	`UnrealizedGainLossOnInvestments`	-	USD	Annual
Proceeds from sale of investments	`GainLossOnSaleOfInvestments`	-	USD	Annual
Proceeds from sale of investments	`GainLossOnSaleOfInvestments`	-	USD	Annual
Proceeds from sale of investments	`GainLossOnSaleOfInvestments`	$-88.73K	USD	Annual
Increase in interest receivable	`IncreaseDecreaseInInterestAndDividendsReceivable`	-	USD	Annual
Increase in interest receivable	`IncreaseDecreaseInInterestAndDividendsReceivable`	-	USD	Annual
Increase in interest receivable	`IncreaseDecreaseInInterestAndDividendsReceivable`	$600.00	USD	Annual
Increase (decrease) in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$17.97K	USD	Annual
Increase (decrease) in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-17.76K	USD	Annual
Increase (decrease) in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$3.50K	USD	Annual
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-21.47K	USD	Annual
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-46.30K	USD	Annual
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-181.61K	USD	Annual
Proceeds from notes payable	`ProceedsFromNotesPayable`	-	USD	Annual
Proceeds from notes payable	`ProceedsFromNotesPayable`	-	USD	Annual
Proceeds from notes payable	`ProceedsFromNotesPayable`	$20.00K	USD	Annual
Repayment of notes payable	`ProceedsFromRepaymentsOfNotesPayable`	-	USD	Annual
Repayment of notes payable	`ProceedsFromRepaymentsOfNotesPayable`	$-5.00K	USD	Annual
Repayment of notes payable	`ProceedsFromRepaymentsOfNotesPayable`	-	USD	Annual
Proceeds from issuance of redeemable Series A, Convertible Preferred Stock	`ProceedsFromIssuanceOfConvertiblePreferredStock`	-	USD	Annual
Proceeds from issuance of redeemable Series A, Convertible Preferred Stock	`ProceedsFromIssuanceOfConvertiblePreferredStock`	-	USD	Annual
Proceeds from issuance of redeemable Series A, Convertible Preferred Stock	`ProceedsFromIssuanceOfConvertiblePreferredStock`	$400.00K	USD	Annual
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$2.00M	USD	Annual
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$575.00	USD	Annual
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Payment of direct offering costs	`PaymentForDirectOfferingCostsInCash`	$198.05K	USD	Annual
Payment of direct offering costs	`PaymentForDirectOfferingCostsInCash`	-	USD	Annual
Payment of direct offering costs	`PaymentForDirectOfferingCostsInCash`	-	USD	Annual
Net Cash Provided By Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$2.19M	USD	Annual
Net Cash Provided By Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$20.00K	USD	Annual
Net Cash Provided By Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$575.00	USD	Annual
Net Increase (Decrease) in Cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-45.73K	USD	Annual
Net Increase (Decrease) in Cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.47K	USD	Annual
Net Increase (Decrease) in Cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$2.01M	USD	Annual
Cash and cash equivalents - Beginning of Year	`CashAndCashEquivalentsAtCarryingValue`	$47.48K	USD	Point-in-time
Cash and cash equivalents - Beginning of Year	`CashAndCashEquivalentsAtCarryingValue`	$1.75K	USD	Point-in-time
Cash and cash equivalents - Beginning of Year	`CashAndCashEquivalentsAtCarryingValue`	$2.01M	USD	Point-in-time
Cash and cash equivalents - Beginning of Year	`CashAndCashEquivalentsAtCarryingValue`	$279.00	USD	Point-in-time
Cash and cash equivalents - End of Year	`CashAndCashEquivalentsAtCarryingValue`	$47.48K	USD	Point-in-time
Cash and cash equivalents - End of Year	`CashAndCashEquivalentsAtCarryingValue`	$1.75K	USD	Point-in-time
Cash and cash equivalents - End of Year	`CashAndCashEquivalentsAtCarryingValue`	$2.01M	USD	Point-in-time
Cash and cash equivalents - End of Year	`CashAndCashEquivalentsAtCarryingValue`	$279.00	USD	Point-in-time
Interest paid	`InterestPaid`	-	USD	Annual
Interest paid	`InterestPaid`	-	USD	Annual
Interest paid	`InterestPaid`	$1.14K	USD	Annual

Stockholders Equity 20 line items

Line Item	Tag	Value	Unit	Period
Common Stock, Par Or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, Par Or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock issued, Par Value	`StockIssuedDuringPeriodParValue`	$0.20	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$-41.19K	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$-1.75K	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$47.48K	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$1.79M	USD	Point-in-time
Receipt of subscription receivable	`StockholdersEquityOther`	$575.00	USD	Annual
Common stock issued ($0.20/share)	`StockIssuedDuringPeriodValueIssuedForServices`	$1.07M	USD	2 Qtrs
Common stock issued ($0.20/share)	`StockIssuedDuringPeriodValueIssuedForServices`	$2.00M	USD	Annual
Common stock issued ($0.20/share), shares	`StockIssuedDuringPeriodSharesIssuedForServices`	21.50M	shares	2 Qtrs
Offering costs	`AdjustmentsToAdditionalPaidinCapitalDirectOfferingCosts`	$-198.05K	USD	Annual
Net loss	`NetIncomeLoss`	-	USD	Annual
Net loss	`NetIncomeLoss`	$-39.45K	USD	Annual
Net loss	`NetIncomeLoss`	$-49.80K	USD	Annual
Increase (decrease) in net assets resulting from operations	`IncreaseDecreaseInNetAssetsResultingFromOperations`	$32.91K	USD	Annual
Balance	`StockholdersEquity`	$-41.19K	USD	Point-in-time
Balance	`StockholdersEquity`	$-1.75K	USD	Point-in-time
Balance	`StockholdersEquity`	$47.48K	USD	Point-in-time
Balance	`StockholdersEquity`	$1.79M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.